1. Home
  2. HWM vs VRTX Comparison

HWM vs VRTX Comparison

Compare HWM & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Howmet Aerospace Inc.

HWM

Howmet Aerospace Inc.

HOLD

Current Price

$287.09

Market Cap

111.2B

Sector

Industrials

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$473.09

Market Cap

123.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
HWM
VRTX
Founded
1888
1989
Country
United States
United States
Employees
25430
N/A
Industry
Metal Fabrications
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
111.2B
123.4B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
HWM
VRTX
Price
$287.09
$473.09
Analyst Decision
Strong Buy
Buy
Analyst Count
14
29
Target Price
$243.21
$539.69
AVG Volume (30 Days)
2.7M
1.6M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
0.20%
N/A
EPS Growth
N/A
836.54
EPS
N/A
4.02
Revenue
N/A
$2,488,652,000.00
Revenue This Year
$14.58
$10.79
Revenue Next Year
$12.34
$10.47
P/E Ratio
$67.21
$117.55
Revenue Growth
N/A
46.20
52 Week Low
$169.45
$362.50
52 Week High
$290.63
$533.67

Technical Indicators

Market Signals
Indicator
HWM
VRTX
Relative Strength Index (RSI) 59.38 43.30
Support Level $261.80 $422.12
Resistance Level $280.62 $486.26
Average True Range (ATR) 7.27 14.12
MACD 0.21 -4.76
Stochastic Oscillator 90.54 3.26

Price Performance

Historical Comparison
HWM
VRTX

About HWM Howmet Aerospace Inc.

Howmet Aerospace Inc offers engineered solutions for the aerospace and transportation industries. The company's products and solutions include investment castings for jet engines and industrial gas turbines; seamless rolled rings for jet engines; fastening systems for aerospace, industrial and commercial transportation applications; forged jet engine components (e.g., jet engine disks); machined and forged aircraft parts; and forged aluminum commercial vehicle wheels, all of which are sold directly to customers or through distributors. It has four reportable segments: Engine Products, which derives key revenue, Fastening Systems, Engineered Structures, and Forged Wheels. Geographically, the company derives maximum revenue from the USA, followed by France, Japan, Germany, and other markets.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: